logo
15 Minutes of This Exercise May Lower Mortality Risk by 19%, New Study Says

15 Minutes of This Exercise May Lower Mortality Risk by 19%, New Study Says

Yahoo3 days ago
Reviewed by Dietitian Mandy Enright, M.S., RDN, RYTKey Points
A new study found that 15 minutes of fast walking each day may lower mortality risk by 19%.
Fast walking lowered overall mortality risk and had an especially large impact on heart health-related deaths.
While slower walking can be a great form of exercise, smaller quantities of fast walking may offer extra benefits.Walking is one of the simplest and most effective ways to boost overall health, as it can offer benefits like reduced mortality, improved blood sugar levels and better heart health. Studies suggest that even light walking can have a positive impact on outcomes like reducing blood pressure.
But most research on walking focuses on middle-to-high-income white populations, leaving gaps in understanding how walking impacts low-income and racial minority groups. These populations often face unique challenges, such as limited access to safe walking spaces, higher exposure to pollution and barriers to healthcare, all of which can contribute to higher mortality rates.
To address the lack of research on walking in underserved communities, scientists used data from the Southern Community Cohort Study (SCCS) to explore how daily walking impacts overall and specific causes of mortality, and the results were published in the American Journal of Prevention Medicine.
How Was The Study Conducted?
This study enrolled about 85,000 participants aged 40 to 79 from the Southern Community Cohort Study (SCCS), focusing on individuals who had not undergone cancer treatment in the year prior to joining. The SCCS is a large study focused on understanding why racial disparities exist in cancer and other chronic diseases, particularly in low-income populations. What makes this study unique is that over half of the participants reported earning less than $15,000 a year, and about two-thirds of them are Black. This diverse group offers a rare chance to examine how daily walking affects health outcomes in low-income, racially diverse populations.
At the start of the study, participants completed detailed questionnaires covering their daily walking habits, lifestyle choices and medical history.
Participants reported how much time they spent walking each day, distinguishing between slow walking (e.g., walking the dog or light exercise) and fast walking (e.g., brisk walking or climbing stairs). They could report anywhere from 0 to 720 minutes per day, and their responses were grouped into four categories: no walking, less than 30 minutes, 30-60 minutes and more than 60 minutes. These categories align with health guidelines recommending at least 30 minutes of daily activity. The study also explored fast walking in smaller increments (e.g., 15-minute intervals).
In addition to walking, the study measured five key lifestyle factors linked to mortality: smoking, alcohol use, physical activity, sedentary behavior and diet quality. These factors were combined into a composite lifestyle score, with higher scores indicating healthier lifestyles.
The study tracked participants' vital status and causes of death through the National Death Index until December 31, 2022. Deaths were categorized into major causes, including cardiovascular disease (CVD), cancer, other diseases and external causes like accidents. Specific types of CVD, such as heart disease and stroke, were also analyzed due to their prevalence. This comprehensive approach allowed researchers to examine how daily walking and lifestyle factors influence overall and cause-specific mortality in a diverse, low-income population.
What Did This Study Find?
The study found that, among the studied population, fast walking was significantly linked to lower overall mortality, while slow walking showed only a slight, non-significant benefit. For those who walked slowly for more than three hours a day, there was a 4% lower risk of death, but this result wasn't strong enough to be considered statistically significant. On the other hand, fast walking showed clear benefits; even just 15 minutes a day was associated with a 19% lower risk of death.
When researchers accounted for other lifestyle factors like diet, smoking and physical activity, the benefits of fast walking remained strong, while the slight benefits of slow walking became even less noticeable. Overall, fast walking stood out as a simple and effective way to reduce the risk of death.
Additional analyses confirmed the findings, showing consistent results for the link between time spent walking (both slow and fast) and overall mortality, even when including participants who died within the first two years. Fast walking showed similar patterns of reduced risk across all specific causes of death, but the strongest benefits were seen for cardiovascular disease (CVD). People who walked fast for more than 60 minutes a day had a 20% lower risk of dying from CVD compared to those who didn't walk at all. Within CVD, the biggest reductions in risk were seen for heart diseases, particularly ischemic heart disease and heart failure.
Interestingly, the benefits of fast walking were independent of other physical activities, meaning fast walking provided its own unique health boost. Even for individuals who were already active, those who walked fast for more than 60 minutes a day saw additional benefits, with a 16% lower risk of death compared to those who didn't walk fast at all.
There are a few limitations to keep in mind when interpreting these results. First, since participants reported their own daily walking habits, some may have included other activities like climbing stairs, which could lead to some misclassification. Second, physical activity data was only collected at the start of the study, so it wasn't possible to see how changes in activity over time might affect the results. Additionally, because this was an observational study, it's hard to completely rule out other factors, like pre-existing health conditions or unmeasured influences, that could have impacted the findings.
How Does This Apply To Real Life?
This study highlights that walking, especially fast walking, can be a powerful tool for improving health and reducing the risk of death, even with just 15 minutes a day. For people who may not have access to gyms or structured exercise programs, walking offers an easy, low-cost way to stay active. The findings are particularly important for underserved communities, where barriers like limited access to safe walking spaces or healthcare can make it harder to prioritize health.
The study also emphasizes that fast walking has unique benefits, even for those who are already active or engage in other forms of exercise. This means that adding a brisk walk to your daily routine can complement other activities and provide an extra health boost. Whether it's a quick walk around the block, climbing stairs at work, or picking up the pace while walking the dog, these small changes can add up. The key takeaway? You don't need fancy equipment or hours of free time; just lace up your shoes, pick up the pace and let your feet do the work for your health.
Our Expert Take
This study published in the American Journal of Prevention Medicine highlights that even small amounts of fast walking (just 15 minutes a day) can make a meaningful difference in overall health and longevity. For those where access to gyms or safe exercise spaces may be limited, this study offers an encouraging and accessible way to improve health outcomes.
The findings also underscore the importance of making walking a part of daily life. Whether it's a brisk walk to the store, a quick loop around the neighborhood or simply picking up the pace during your usual routine, fast walking is a simple, low-cost activity with big health payoffs. Grab your sneakers, step outside and start reaping the benefits—your heart (and the rest of your body) will thank you.
Read the original article on EATINGWELL
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino joins health tech platform eMed as CEO after leaving X

TechCrunch

time31 minutes ago

  • TechCrunch

Linda Yaccarino joins health tech platform eMed as CEO after leaving X

Linda Yaccarino's next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive impact on the social network's troubled ad revenue model, despite her and Elon Musk's shared approach to minimizing content moderation. Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her 'undeniable ability to negotiate new partnerships' — it certainly also helps that her tenure at X made her well-known in the tech world, drawing more eyes toward the startup. eMed previously produced a tech platform that was designed to be used with at-home COVID-19 rapid antigen tests, guiding users through the process of administering these tests properly. Now, eMed is focused on GLP-1s, the class of drugs like Ozempic, which can be used for both weight management and treatment of type II diabetes. 'To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,' Yaccarino said in a press release. 'We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms.'

NASA and Congress Wrestle Over the Space Station—and How to Replace It
NASA and Congress Wrestle Over the Space Station—and How to Replace It

Wall Street Journal

time32 minutes ago

  • Wall Street Journal

NASA and Congress Wrestle Over the Space Station—and How to Replace It

The fight over government spending is reaching 250 miles above the Earth's surface. The International Space Station for more than two decades has been the centerpiece of human spaceflight at the National Aeronautics and Space Administration. Government leaders are now jousting over funding for the ISS, while NASA is signaling it will start pulling back on some station activities ahead of its planned decommissioning in 2030, when private space stations are envisioned taking its place.

From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health
From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

Yahoo

timean hour ago

  • Yahoo

From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health

Fellow Health just raised $24 million in a Series B funding round, bringing its cash haul across multiple offerings to $48 million. The San Leandro, California startup advances male reproductive health through "patient-centric testing solutions" and plans to use the capital infusion to expand its mail-in semen analysis services. Fellow Health provides clinical grade, mail-in analysis of male fertility and post-vasectomy status while committing to "privacy, convenience and timely results." Italready has a network of more than 2,500 fertility and urology providers nationwide and wants to "deepen its footprint" through expansion into employer-sponsored fertility benefits and "broader access initiatives." Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — Accredited Investors: Grab Pre-IPO Shares of the AI Company Powering Hasbro, Sephora & MGM— led the latest funding round, in which asset management firm Forest Road participated for the first time. Forest Managing Partner of Life Sciences Bill Burkoth will join Fellow's board as part of the financing deal. Other investors since the initial round include Labcorp Venture Fund, Genoa Ventures and Mantis Venture Capital. "Fellow Health is exactly the kind of company we look for – operating in a large, overlooked market that's long overdue for disruption," Burkoth said in a statement. "With over 50,000 test results delivered so far this year, they've proven there is real demand for a better patient experience." Live sperm gets counted in fertility analysis. These cells can live three to days within the cervix, uterus and fallopian tubes, but usually die in under an hour outside a woman's body. The mail-in service addresses this time bomb with a "preservation solution designed to stabilize your sample and a gel pack that helps maintain a moderate temperature during transit." Mail-in post-vasectomy testing is less time critical because it counts both living and dead sperm. Trending: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Fellow Health points to studies backing up its claim that it can provide "results on par with traditional one-hour semen analysis when analyzing samples received within 52 hours of when they were produced." It sells both testing products and a cryopreservation service without a doctor's prescription at its website. 'Male reproductive health should not be reactive or inaccessible,' Fellow CEO Brian Hogan said in the statement. 'We are on track to deliver over 40% year-over-year revenue growth, with a path to profitability in our fertility segment by 2026. This investment allows us to scale that vision and support both patients and providers with modern tools that work.'However, Fellow Health faces stiff competition in the male fertility space that could impact this optimistic revenue outlook. Rival Posterity Health booked $13 million in Series A funding earlier this year. The company partnered with Mark Cuban Cost Plus Drug Company in 2023 to provide access to treatments for infertility, sexual dysfunction and low testosterone. A year earlier, American telehealth provider Ro bought Dadi, another male fertility and sperm testing startup. Its reproduction preservation service for men looks like a direct competitor to Fellow Health's family of products. Ro has also made a splash in women's health, acquiring Modern Fertility in 2021. Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article From Taboo To Tech: Fellow Health's $24M Raise Signals Big Shift In Men's Reproductive Health originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store